US Centers for Disease Control and Prevention (CDC) suspends testing for multiple infectious diseases
Change
The CDC suspended more than two dozen diagnostic tests, including assays for rabies, poxviruses, Epstein-Barr virus and varicella zoster virus, citing workforce reductions, and said it can assist state and local partners in coordinating testing through alternative laboratories.
Why it matters
State and local public-health laboratories that rely on CDC laboratory support can no longer send samples for the paused assays and must find alternate testing providers or delay diagnoses. Laboratories without commercial capacity will face constrained access to specialised confirmation testing and must change sample-routing procedures to maintain surveillance.
Implications
- • Directors of state and local public-health laboratories must immediately secure contracts or transfer agreements with commercial or other public laboratories for the paused assays, or diagnostic confirmations will be delayed.
- • State and local health departments' epidemiology and surveillance teams must revise testing workflows and reporting protocols to route samples to alternate laboratories, or surveillance and case counting will lapse.
Unlock the decision layer.
Go beyond headlines — see impact, exposure, and timing.
- Implications: What actually changes downstream.
- Who is affected: Which teams or operators are exposed.
- What to watch: Deadlines, triggers, and next moves.
- Real-time alerts: Know the moment a change is published.
- Ask AI: Clarify any brief instantly, in context.
14-day free trial. Full access. No credit card required.
Start free trial
Source
Topics